A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Clinical trial NCT07285655 · RECRUITING

Trial details

NCT number: NCT07285655
Sponsor: Liquidia Technologies, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension Due to Lung Disease (Disorder)

Start date: 2026-04-23
Primary completion: 2029-07-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.